U.S. Traders May Be Accidentally Buying This Biotech Stock – But It May Be Worth Owning Anyways!
Shares of the biotech highlighted in today’s article have soared this year, but is this performance due to factors such as the COVID-19 drug the…
On the Radar Reports
What To Know About These Top Biotech Stocks To Watch
“July is a critical month for several leading biotech companies, and there’s a lot that investors need to know if they want to make a…
Options For An Uncertain Earnings Season
With second-quarter earnings season getting underway against what the author of today’s article acknowledges is “one of the most uncertain backdrops ever”, he advises that…
These 5 “Magic Formula” Biotech Stocks Are Guru Approved
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
These 10 High-Risk Stocks Are Defying Conventional Wisdom And Charging Higher
High-risk stocks have soared since the March selloff. As the author of today’s article observes, “In essence, most investors on Wall Street are positioning for…
Follow The Analysts To Massive Upside Potential From These 3 Micro-Cap Stocks
“If you are looking to hit a home run in the stock market, the NASDAQ Composite is a good place to start,” advises the author…
Biotech Boomers To Buy
When it comes to biotech stocks, the author of today’s article advises that “While you can get access to many of these firms via exchange-traded…
Why These 2 Under-The-Radar Biotech Stocks Are Poised To Dominate This Year And Beyond
The two small-cap biotech stocks highlighted in today’s article appear poised to dominate this year and beyond. Why? As the author explains, “Both companies are…
Market Volatility Could Be Exacerbated This Week (And Beyond) – And Not Just Because Of Coronavirus
The stock market could be in for an especially volatile time this week and into July – and while the acceleration in new coronavirus cases…
“Focus On The Fundamentals”: 2 Biotech Stocks With Upcoming Catalysts Unrelated To COVID-19
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…